Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

CYTOMED THERAPEUTICS LIMITED

Contributing Author

Recent Articles by CYTOMED THERAPEUTICS LIMITED

Jan-28	CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress GDTC GlobeNewswire
Jan-13	CytoMed Therapeutics' new year update and seeks shareholders' feedback on proposal to improve shareholder value for their patient capital GDTC GlobeNewswire
Dec-08	CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia GDTC GlobeNewswire
Nov-18	CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India GDTC GlobeNewswire
Nov-06	CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy GDTC GlobeNewswire
Oct-22	CytoMed Therapeutics' Chairman Increases Effective Holdings to 21.95% GDTC GlobeNewswire
Oct-14	CytoMed makes cash bid for potential acquisition of TC BioPharm Limited's relevant assets GDTC +16.58% GlobeNewswire
Oct-02	CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia GDTC GlobeNewswire
Aug-28	Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition GDTC GlobeNewswire
Aug-18	CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program GDTC GlobeNewswire
Jul-21	Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies GDTC GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)